Clinical trial
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian…
NCT00003334 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00003334 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract |
| Official title | Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | paclitaxel, pegylated liposomal doxorubicin hydrochloride |
| Start date | Mar 1, 1997 |
| Primary completion | Dec 1, 2001 |
| First posted | Feb 9, 2004 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: